Pomegranate (Punica granatum L.) fruits are widely consumed as juice (PJ). The potent antioxidant and anti-atherosclerotic activities of PJ are attributed to its polyphenols including punicalagin, the major fruit ellagitannin, and ellagic acid (EA). Punicalagin is the major antioxidant polyphenol ingredient in PJ. Punicalagin, EA, a standardized total pomegranate tannin (TPT) extract and PJ were evaluated for in vitro antiproliferative, apoptotic and antioxidant activities. Punicalagin, EA and TPT were evaluated for antiproliferative activity at 12.5-100 mu g/ml on human oral (KB, CAL27), colon (HT-29, HCT116, SW480, SW620) and prostate (RWPE-1, 22Rv1) tumor cells. Punicalagin, EA and TPT were evaluated at 100 mu g/ml concentrations for apoptotic effects and at 10 mu g/ml concentrations for antioxidant properties. However, to evaluate the synergistic and/or additive contributions from other PJ phytochemicals, PJ was tested at concentrations normalized to deliver equivalent amounts of punicalagin (w/w). Apoptotic effects were evaluated against the HT-29 and HCT116 colon cancer cell lines. Antioxidant effects eScholarship provides open access, scholarly publishing services to the University of California and delivers a dynamic research platform to scholars worldwide.
Epidemiological studies suggest that a reduced risk of cancer is associated with the 3 consumption of a phytochemical rich diet that includes fruits and vegetables [1] [2] [3] . Fresh 4 and processed fruits and food products contain high levels of a diverse range of 5 phytochemicals of which polyphenols including hydrolysable tannins [ellagitannins (ETs) 6
and gallotannins] and condensed tannins (proanthocyanidins), and anthocyanins and other 7 flavonoids make up a large proportion [4] [5] [6] [7] . Suggested mechanisms of anticancer effects 8 of polyphenols include antioxidant, anti-inflammatory, and antiproliferative activities as 9 well as their effects on sub-cellular signaling pathways, induction of cell cycle arrest and 10 apoptosis [1, 8, 9] . 11 Pomegranate (Punica granatum L.) fruits are widely consumed fresh and in 12 beverage forms as juice and wines [10] . Commercial pomegranate juice (PJ) shows 13 potent antioxidant and anti-atherosclerotic properties attributed to its high content of 14 polyphenols including ellagic acid (EA) in its free and bound forms [as ETs, and EA-15 glycosides (EAGs)], gallotannins, and anthocyanins (cyanidin, delphinidin and 16 pelargonidin glycosides) and other flavonoids (quercetin, kaempferol and luteolin 17 glycosides) [10] [11] [12] [13] [14] [15] . The most abundant of these polyphenols is punicalagin (Fig. 1) , an 18 ET implicated as the bioactive constituent responsible for >50% of the juice's potent 19 antioxidant activity [10] . Punicalagin is abundant in the fruit husk and during processing 20 is extracted into PJ in significant quantities reaching levels of > 2g/L juice [10, [14] [15] [16] . 21 We are interested in the potential health benefits of phytochemicals and 22 evaluating the multifactorial effects and chemical synergy of the action of multiple 23 compounds, as found naturally in their unique compositions in foods compared to single 1 purified active compounds [17] . Because pomegranates are widely consumed and 2 implicated with potential human health benefits [11, 18] , we have investigated the 3 antiproliferative, apoptotic and antioxidant activities (lipid peroxidation inhibitory and 4
Trolox Equivalent Antioxidative Capacity) of its polyphenols. Pomegranate was 5 evaluated in the form of PJ, a popularly consumed beverage, as a standardized total 6 pomegranate tannin (TPT) extract (contains 85% punicalagin anomers, 1.3% EA, ~12% 7 minor ETs and EAGs) [16] , and as its reported active ingredients, punicalagin and EA. 8 EA has previously been shown to exhibit anticarcinogenic properties such as 9 induction of cell cycle arrest and apoptosis, as well as the inhibition of tumor formation 10 and growth in animals [19] [20] [21] . Hydrolysable and condensed tannins have also been 11 reported to show in vitro and in vivo anticancer properties [22] [23] [24] . However, this is the 12 first report on the evaluation of PJ and TPT and their major purified polyphenols, 13 punicalagin and EA, for antiproliferative activity against this panel of human oral (KB, 14 CAL27), colon (HT-29, HCT116, SW480, SW620) and prostate (RWPE-1, 22Rv1) 15 cancer cell lines. This is also the first report on the inhibition of lipid peroxidation by 16 pomegranate polyphenols using a model of liposome oxidation by fluorescence 17 spectroscopy and on the evaluation of their apoptotic effects against human colon cancer 18 Ellagitannins were purified from fruit husk as previously reported and analyzed for 10 purity by high performance liquid chromatography (HPLC) and liquid chromatography 11 electrospray ionization mass spectroscopy (LC-ESI/MS) [16] .
Briefly, an aqueous 12 extract of fruit husk was adsorbed on an Amberlite XAD-16 resin column, eluted with 13 water, and then the adsorbed total pomegranate tannins (TPT) were eluted with methanol. 14 Pure punicalagin anomers were then obtained by chromatography of TPT on a Sephadex-15 LH20 resin column using gradient elution with a water: methanol: acetone solvent 16 system. HPLC and LCMS analyses showed that TPT contains 85% punicalagin anomers 17 µL control media, ascorbic acid (100 µM, used as an antioxidant standard), or test 22 samples and incubated for 48h drug exposure duration. Punicalagin, EA and TPT were 23 tested at 12.5, 25, 50 and 100 µg/mL concentrations. PJ was tested at concentrations 1 normalized to deliver equivalent amounts of punicalagin (w/w) to evaluate the additive 2 and/or synergistic effects of other pomegranate phytochemicals towards its 3 antiproliferative activity. At the end of 48 h, plates were equilibrated at room 4 temperature for 30 min, 100 µL of the assay reagent was added to each well and cell-lysis 5 was induced on an orbital shaker for 2 min. Plates were incubated at room temperature 6 for 10 min to stabilize the luminescence signal and results were read on an Orion 7
Microplate Luminometer (Bertholds Detection Systems, Pforzheim, Germany). All 8 plates had control wells containing medium without cells to obtain a value for 9 background luminescence. Data are expressed as percentage of untreated cells, mean ± 10 SE for three replications 11 The biological properties associated with pomegranate fruits [10] [11] [12] [13] prompted us 1 to evaluate their major phytochemical ingredients as single purified compounds, 2 punicalagin and EA (Fig. 1) , and as combinations, TPT and PJ. 3
We have previously reported that TPT contains 85% punicalagin, 1.3% EA-4 hexoside and minor EAGs and ETs (punicalin and gallagic acid) [16] . The minor 5 pomegranate ETs and EAGs were not quantified in TPT due to the unavailability of 6 commercial standards. The PJ used in our experiments contained 1.74 mg/mL 7 punicalagin and 0.14 mg/mL EA. 8
Test samples were evaluated for antiproliferative activity against human oral (KB, 9 CAL27), colon (SW460; SW620; HT-29; HCT116) and prostate (RWPE-1; 22Rv1) 10 tumor cells. At concentrations normalized to deliver equivalent amounts of the major 11 pomegranate polyphenol, punicalagin (w/w), PJ showed greatest antiproliferative activity 12 against all cell lines by inhibiting proliferation from 30-100% at treatments between 12.5-13 100 µg/mL (Figs. 2-4) . Punicalagin, EA and TPT inhibited cell proliferation in a dose 14 dependent manner in all cell lines tested, but to a lesser degree than PJ. In KB oral 15 cancer cells, EA inhibited proliferation from 45-88%, punicalagin from 0-42% and TPT 16 from 0-27% ( Fig. 2A) . In CAL27 oral cancer cells, EA inhibited cell proliferation from 17 26-69%, punicalagin from 10-96% and TPT from 17-97% (Fig. 2B) . SW480 non-18 metastatic colon cancer cells also showed sensitivity to pomegranate polyphenols with 19 EA inhibiting cell proliferation from 49-76%, punicalagin from 1-65% and TPT from 1-20 67% (Fig. 3A) . In SW620 metastatic colon cancer cells, EA inhibited proliferation from 21 14-35%, punicalagin from 0-57% and TPT from 0.02-40% (Fig. 3B) . Proliferation of 22
HT-29 colon cancer cells was inhibited from 0-21% by EA, from 1-55% by punicalagin 23 and from 2-71% by TPT (Fig. 3C ) and in HCT116 colon cancer cells, EA induced 1 inhibition of proliferation from 53-87%, punicalagin from 0-72% and TPT from 13-87% 2 (Fig. 3D) . Similarly, in RWPE-1 immortalized prostate epithelial cells, EA inhibited 3 proliferation from 78-92%, punicalagin from 64-94% and TPT from 44-88% (Fig. 4A) . 4 In 22Rv1 metastatic prostate cancer cells, EA inhibited proliferation from 43-94%, 5 punicalagin from 68-90% and TPT from 47-89% at treatments between 12.5-100 µg/mL 6 (Fig. 4B) . 7
Because of our specific interest in colon cancer, the apoptotic effect of PJ and its 8 purified polyphenols on the HT-29 and HCT116 colon cancer cell lines were evaluated to 9 ascertain whether the observed reduction in viable cell number was due to the induction 10 of apoptosis (Fig. 5) . At doses held equivalent to that found in PJ, punicalagin, EA, and 11
TPT did not exhibit apoptotic activity in HT-29 and HCT116 colon cancer cell lines (data 12 not shown). However, when treated at equivalent doses of 100 µg/mL, PJ, EA, abilities of the samples to inhibit lipid peroxidation were compared to that of the 22 commercial antioxidants, TBHQ, BHT and BHA (all at 10 µM concentrations) (Fig. 6) . 23
In the lipid peroxidation assay, the relative decrease in fluorescence showed that PJ was 1 the most active sample among the pomegranate polyphenols tested (Fig. 6) The major pomegranate ET, punicalagin, is reported as the active ingredient responsible 19 for > 50% of the juice's antioxidative potential [10, 29] and can reach levels of > 2g/L of 20 juice (10) . However the synergistic and/or additive effects of the individual purified 21 polyphenols present in PJ and also in a well standardized extract form are yet to be 22 evaluated for anti-proliferative and apoptotic activities.
In addition, although 23 hydrolysable tannins and EA have been reported to have anticancer activities [22] [23] [24] 36 ], 1 punicalagin, has never been evaluated for its antiproliferative and apoptotic properties. 2
These in vitro studies are necessary since punicalagin has been shown to release EA, 3 which is then metabolized in vivo to its glucuronides and sulfates in animal and human 4 bioavailability studies [14, 15, 37, 38] . 5
In the present study, punicalagin, EA and TPT decreased viable cell number of 6 human oral (Fig. 2), prostate (Fig. 3) and colon (Fig. 4) tumor cells, however, superior 7 activity was obtained with pure PJ. Similarly, in the apoptosis studies, PJ induced 8 apoptosis in HT-29 cells when concentrations of punicalagin, ET and TPT equalized to 9 amounts found in PJ had no effect. Only when the concentration of these compounds 10 was raised to equivalent amounts (w/w) with PJ were they able to induce apoptosis. Our 11 finding that PJ is more potent than its separated polyphenols suggests synergistic and/or 12 additive effects from the other phytochemicals present in PJ. This finding is not 13 surprising, as PJ also contains proanthocyanidins, anthocyanins (glycosides of 14 delphinidin, peonidin and cyanidin), and flavonoid glycosides [10] [11] [12] [13] 
